Similar articles

• Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension.

  Bühler FR, Tkachuk VA, Hahn AW, Resink TJ. Bühler FR, et al. J Hypertens Suppl. 1991 Dec;9(6):S28-36. J Hypertens Suppl. 1991. PMID: 1818968 Review.
• [Hyperlipoproteinemia and its role in the pathogenesis of arteriosclerosis].

  Klimov AN. Klimov AN. Patol Fiziol Eksp Ter. 1972 Sep-Oct;16(5):3-12. Patol Fiziol Eksp Ter. 1972. PMID: 4363573 Review. Russian. No abstract available.
• Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.

  Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P. Mertens A, et al. Circulation. 2003 Apr 1;107(12):1640-6. doi: 10.1161/01.CIR.0000056523.08033.9F. Epub 2003 Mar 24. Circulation. 2003. PMID: 12668499
• [Pathogenetic importance of prostacyclin in atherosclerosis].

  Efimov VV, Ladnyĭ AI. Efimov VV, et al. Ter Arkh. 1985;57(9):142-8. Ter Arkh. 1985. PMID: 3909478 Review. Russian. No abstract available.
• Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.

  Chapman MJ, Guérin M, Bruckert E. Chapman MJ, et al. Eur Heart J. 1998 Feb;19 Suppl A:A24-30. Eur Heart J. 1998. PMID: 9519339 Review.